Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

“살 빼는 약, 가격 절반으로 뚝” 일라이릴리, ‘젭바운드’ 주사액 출시 #shortsПодробнее

Inside the pharmacies creating 'copycat' versions of weight-loss drugsПодробнее

Eli Lilly cuts price for weight-loss drug ZepboundПодробнее

Eli Lilly offers discounted Zepbound vials at half the usual monthly costПодробнее

Eli Lilly slashes prices of low doses of weight loss drug by scrapping auto-injectorПодробнее

Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vialsПодробнее

HIMS Stock Crashing - What Happened? Eli Lilly HUGE NEWS... Time to SELL?Подробнее

Exclusive: How Eli Lilly’s making weight loss drugs more accessibleПодробнее

Eli Lilly's Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita PatelПодробнее

Eil Lilly announces Zepbound to be sold directly to consumersПодробнее

Eli Lilly to offer weight loss drug directly to qualifying customers at lower priceПодробнее

Eli Lilly to sell popular weight loss medication directly to consumers without insurance coverageПодробнее

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to knowПодробнее

Lilly Lowers Forecast on Weight-Loss DisappointmentПодробнее

Eli Lilly to sell Zepbound directly to consumers without insuranceПодробнее

Eli Lilly lowers out of pocket cost for weight loss drug ZepboundПодробнее

Eli Lilly’s Bold Move to Expand Access to Weight Loss DrugПодробнее